摩根士丹利給予農夫山泉同等權重評級,股價已反映基本面和增長預期
uSMART友信智投10月8日消息,據彭博,摩根士丹利對農夫山泉初始評級爲同等權重,該股自上個月上市以來已飆升71%。摩根士丹利認爲股價已反映堅實基本面和投資者對其盈利增長的預期。
分析師Lillian Lou等人在報告中表示,摩根士丹利對農夫山泉實現可持續增長的能力有信心,但建議投資者在等待股票回撤後再介入。目標價爲33港元,較週三收盤低10%。
報告認爲,在品牌定位、關鍵原材料控制和有效供應鏈管理的幫助下,農夫山泉在核心水務領域保持強勢,2020-2022年公司盈利的複合年增長率料在19%。
此外,中金公司給予農夫山泉買入的初始評級,目標價爲41.5港幣。對公司在軟飲料行業的市場份額持續擴張持樂觀態度,瓶裝水在中國份額最大,去年爲20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.